Abstract
Kell (’Kelleher’) is a complex blood group system of human erythrocytes, 21 antigens of which have been thus far described [7,20] (Tab. 16.1). The Kell phenotypes of human erythrocytes are controlled by two proteins, which are encoded by two independent genes: the Kell antigens per se are produced by alleles of an autosomal gene, KEL,which has been located on chromosome 7q33–q35 [18,23,27,41]. The expression of the Kell antigens on the red cell is controlled by another protein, Kx, which is encoded by the XK gene situated on the short arm of the X chromosome at Xp21 [4,8].
Chapter PDF
Keywords
- Blood Group
- Human Erythrocyte
- Chronic Granulomatous Disease
- Blood Group Antigen
- Potential Phosphorylation Site
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Reference
Advani, H., Zamor, J., Judd, W.J., Johnson, C.L. & Marsh, W.L. (1982): Inactivation of Kell blood group antigens by 2-aminoethylisothiouronium bromide. Brit. J. Haematol. 51, 107–115.
Allen, F.H., Krabbe, S.M.R. & Corcoran, P.A. (1961): A new phenotype (McLeod) in the Kell blood group system. Vox Sang 6, 555–560.
Ballas, S.K., Bator, S M, Aubuchon, J.P., Marsh, W.L., Sharp, D.E. & Toy, E.M. (1990): Abnormal membrane physical properties of red cells in McLeod syndrome. Transfusion 30, 722–727.
Bertelson, C.J., Pogo, A.O., Chaudhuri, A., Marsh, W.L., Redman, C.M., Banerjee, D. & Symmans, W.A. (1988): Localization of the McLeod locus (Xk) within Xp21 by deletion analysis. Amer. J. Hum. Genet. 42, 703–711.
Branch, D.R. & Petz, L.D. (1982) A new reagent (ZZAP) having multiple appplications in immunohematology. Amer. J. Clin. Pathol. 78, 161–167.
Branch, D.R., Muensch, H.A., Sy Siok Han, A.L. & Petz, L.D. (1983): Disulfide bonds are a requirement for Kell and Cartwright (Yta) blood group antigen integrity. Brit. J. Haemato% 54, 573–578.
Daniels, G. (1990): The Kell blood group system: Genetics. In: Blood Group Systems: Kell (B. Laird-Fryer, J. Levitt & G. Daniels eds.), American Association of Blood Banks, Arlington, Virginia, pp. 1–38.
Ho, M.F., Monaco, A.P., Blonden, L.A.J., van Ommen, G.J.B., Affara, N.A., Ferguson-Smith, M.A. & Lehrach, H. (1992): Fine mapping of the McLeod locus (XK) to a 150–380 kb region in Xp21. Amer. J. Hum. Genet. 50, 317–330.
Ho, M.F., Chelly, J., Carter, N., Danek, A., Crocker, P. & Monaco, A.P. (1994): Isolation of the gene for McLeod syndrome that encodes a novel membrane transport protein. Cell 77, 869–880.
Hughes-Jones, N.C. & Gardner, B. (1971): The Kell system: Studies with radioactively-labelled anti-K. Vox Sang. 21, 154–158.
Issitt, P.D. (1985): The Kell blood group system. In: Applied Blood Group Serology. Montgomery Scientific Publications, Miami, FL, USA, 3rd edn., pp. 289–307.
Jaber, A., Blanchard, D., Goosens, D., Bloy, C., Lambin, P., Rouger, P., Salmon, C. & Cartron, J.P. (1989): Characterization of the blood group Kell (K1) antigen with a human monoclonal antibody. Blood 73, 1597–1602.
Judson, P.A. & Anstee, D.J. (1977): Comparative effects of trypsin and chymotrypsin on blood group antigens. Med. Lab. Sci. 34, 1–6.
Kania, Y. & Hediger, M.A. (1992): Primary structure and functional characterization of a high-affinity glutamate transporter. Nature 360, 467–471.
Kanel, G.C., Davis, I. & Bowman, J.E. (1978): “Naturally-occurring” anti-K1: Possible association with mycobacterium infection. Transfusion 18, 472–473.
Kuypers, F.A., van Linde-Sibenius, T.M., Roelofsen, B., op den Kamp, J.A. Tanner, M.J.A. & Anstee, D.J. (1985): The phospholipid organisation in the membranes of McLeod and Leach phenotype erythrocytes. FEBS Lett. 184, 20–24.
Lee, S., Zambas, E.D., Marsh, W.L. & Redman, C.M. (1991): Molecular cloning and primary structure of Kell blood group protein. Proc. Nati. Acad. Scl. U.S.A. 88, 6353–6357.
Lee, S., Zambas, E.D., Marsh, W.L. & Redman, C.M. (1993): The human Kell blood group gene maps to chromosome-7q33 and its expression is restricted to erythroid cells. Blood 81, 2804–2809.
Marsh, W.L., Nichols, M.E., Œyen, R., Thayer, R.S., Deere, W.L., Freed, P.J. & Schmelter, S.E. (1978): Naturally occurring anti-Kell stimulated by E. coli enterocolitis in a 20-day old child. Transfusion 18, 149–154.
Marsh, W.L. & Redman, C.M. (1990): The Kell blood group system: a review. Transfusion 30, 158–167.
McGinniss, M.H., MacLowry, J.D. & Holland, P.V. (1984): Acquisition of K:1-like antigen during terminal sepsis. Transfusion 24, 28–30.
Merry, A.H., Thomson, E.E., Anstee, D.J. & Stratton, F. (1984): The quantification of erythrocyte antigen sites with monoclonal antibodies. Immunology 51, 793–800.
Murphy, M.T., Morrison, N., Miles, J.S., Fraser, R.H., Spurr, N.K. & Boyd, E. (1993): Regional chromosomal assignment of the Kell blood group locus (KEL) to chromosome 7q33-q35 by fluorescence in situ hybridization: evidence for the polypeptide nature of antigenic variation. Hum. Genet. 91, 585–588.
Nichols, M.E., Rosenfield, R.E. & Rubinstein, P. (1987): Monoclonal anti-K14 and anti-K2. Vox Sang. 52, 231–235.
Parsons, S.F., Gardner, B. & Anstee, D.J. (1993): Monoclonal antibodies against Kell glycoprotein: serology, immunochemistry, and quantification of antigen sites. Transfusion Med. 3, 137–142.
Pereira, A., Monteagudo, J. & Rovira, M. (1989): Anti-K1 of the IgA class associated with Morganella morganii infection. Transfusion 29, 549–551.
Purohit, K.R., Weber, J.L., Ward, L.J. & Keats, B.J.B. (1992): The Kell blood group locus is close to the cystic fibrosis locus on chromosome 7. Hum. Genet. 89, 457–458.
Redman, C.M., Marsh, W.L., Mueller, K.A., Avellino, G.P. & Johnson, C.L. (1984): Isolation of Kell-active protein from the red cell membrane. Transfusion 24, 176–178.
Redman, C.M., Avellino, G., Pfeffer, S.R., Mohkerjee, T.K., Nichols, M., Rubinstein, P. & Marsh, W.L. (1986): Kell blood group antigens are part of a 93,000-dalton red cell membrane protein. J. Biol. Chem. 261, 9521–9525.
Redman, C.M., Marsh, W.L., Scarborough, A., Johnson, C.L., Rabin, B.I. & Overbeeke, M. (1988): Biochemical studies on McLeod phenotype red cells and isolation of Kx antigen. Brit. J. Haematol. 68, 131–136.
Redman, C.M., Lee, S., Bokkel Huininck, T., Rabin, B.I., Johnson, C.L., Œyen, R. & Marsh, W.L. (1989): Comparison of human and chimpanzee Kell blood group systems. Transfusion 29, 486–490.
Redman, C.M. & Marsh, W.L. (1993): The Kell blood group system and the McLeod phenotype. Sem. Hemetol. 30, 209–218.
Rouger, P. (1990): Defects of McLeod red blood cells and association with disease. In: Blood Group Systems: Kell(B. Laird-Fryer, J. Levitt & G. Daniels eds.), American Association of Blood Banks, Arlington, Virginia, pp. 77–78.
Savalonis, J.M., Kalish, R.I., Cummings, E.A., Ryan, R.W. & Aloisi, R. (1988): Kell blood group activity of gram-negative bacteria. Transfusion 28, 229–232.
Schultz, M.H. (1990): Serology and clinical significance of Kell blood group system antibodies. In: Blood Group Systems: Kell ( B. Laird-Fryer, J. Levitt & G. Daniels eds.), American Association of Blood Banks, Arlington, Virginia, pp. 37–64.
Seyfried, G.B., Gorska, S., Sylwestrowitz, M.T., Giles, C.M. & Goldsmith, K.L.G. (1972): Apparent depression of antigens of the Kell blood group system associated with autoimmune acquired haemolytic anaemia. Vox Sang. 23, 528–536.
Symmans, W.A., Shepherd, C.S., Marsh, W.L., Œyen, R., Shohet, S.B. & Linehan, B.J. (1979): Hereditary acanthocytosis associated with the McLeod phenotype of the Kell blood group system. Brit. J. Haematol. 42, 575–583.
Tang, L.L., Redman, C.M., Williams, D. & Marsh, W.L. (1981): Biochemical studies on McLeod phenotype erythrocytes. Vox Sang. 40, 17–26.
Vengelen-Tyler, V., Gonzales, B., Garratty, G., Kruppe, C., Johnson, C.L., Mueller, K.A. & Marsh, W.L. (1987): Acquired loss of red cell Kell antigens. Brit. J. Haematol. 65, 231–234.
Wallas, C., Simon, R., Sharpe, M.A. & Byler, C. (1986): Isolation of a Kell-reactive protein from red cell membranes. Transfusion 26, 173–176.
Zelinski, T., Coghlan, G., Myal, Y., White, L.J. & Philipps, S.E. (1991): Assignment of the Kell blood group locus to chromosome 7q. Cytogenet. Cell Genet. 58, 1927.
Author information
Authors and Affiliations
Rights and permissions
Copyright information
© 1995 Springer-Verlag Wien
About this chapter
Cite this chapter
Schenkel-Brunner, H. (1995). Kell. In: Human Blood Groups. Springer, Vienna. https://doi.org/10.1007/978-3-7091-3686-7_16
Download citation
DOI: https://doi.org/10.1007/978-3-7091-3686-7_16
Publisher Name: Springer, Vienna
Print ISBN: 978-3-211-82705-5
Online ISBN: 978-3-7091-3686-7
eBook Packages: Springer Book Archive